Maynard Um
-
-
-
-
-
-
-
Goldman Monthly Update to US Director's Cut List
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance
-
-
-
-
-
-
-
DePuy Synthes names Christina Zamarro as CFO, effective July 2026
-
-
-
-
-
-
-
Johnson & Johnson expands US availability of TECNIS PureSee IOL
-
-
-
-
-
-
-
FDA approves accord Biopharma's Immgolis, a biosimilar to Simponi
-
-
-
-
-
-
-
Johnson & Johnson reports positive phase 2b results for experimental IBD therapy
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $230 at Freedom Broker
-
440,915 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

